1,865
Views
90
CrossRef citations to date
0
Altmetric
CLINICAL REVIEW

Health Status and the Spiral of Decline

Pages 59-63 | Published online: 02 Jul 2009

Figures & data

Figure 1 A model of COPD progression and consequences. The multiple consequences of COPD, including breathlessness, exercise limitation, muscle wasting, fatigue, and exacerbations.

Figure 1 A model of COPD progression and consequences. The multiple consequences of COPD, including breathlessness, exercise limitation, muscle wasting, fatigue, and exacerbations.

Figure 2 Health status and FEV1. In clinical trials of the effect of treatment in COPD, the correlation between changes in FEV1 and SGRQ score is significant, but there is much scatter around the regression line. Source: (Citation[8]).

Figure 2 Health status and FEV1. In clinical trials of the effect of treatment in COPD, the correlation between changes in FEV1 and SGRQ score is significant, but there is much scatter around the regression line. Source: (Citation[8]).

Figure 3 SGRQ and FEV1 Slopes in the Obstructive Lung Disease (ISOLDE) trial (Citation[9]). Deterioration in SGRQ score was only weakly correlated with the decline in FEV1. Source for figure data: Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in copd. Eur Respir J. 2004;23:698–702 (Citation[9]).

Figure 3 SGRQ and FEV1 Slopes in the Obstructive Lung Disease (ISOLDE) trial (Citation[9]). Deterioration in SGRQ score was only weakly correlated with the decline in FEV1. Source for figure data: Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in copd. Eur Respir J. 2004;23:698–702 (Citation[9]).

Table 1 Stepwise multivariate cox proportional hazards analysis to investigate the most significant predictor of mortality in male patients with chronic obstructive pulmonary disease

Figure 4 Withdrawal from treatment as an outcome in the ISOLDE study of COPD. The estimated rate of deterioration in COPD may be skewed by early withdrawal of patients with worse health or faster decline (Citation[19]).

Figure 4 Withdrawal from treatment as an outcome in the ISOLDE study of COPD. The estimated rate of deterioration in COPD may be skewed by early withdrawal of patients with worse health or faster decline (Citation[19]).

Figure 5

Figure 5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.